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ABSTRACT
INTERMITTENT SWIM STRESS EFFECTS ON ANXIETY BEHAVIOR

Timothy A. Warner
University of New Hampshire May 2013
Millions of Americans are suffering from depression each year, leading to
a significant number of individuals who seek treatment for their ailment.
However, fewer than 50 percent of depressed individuals fully recover using
current methods. The comorbidity between depression and anxiety could be a
contributing factor in the lower rates of recovery. The demonstrated correlation
between anxiety and depression has led to the term “anxious depression,” which
is associated with difficulty in coping, a poorer rate of recovery, and more severe
symptoms of depression. The purpose of this dissertation was to expand on an
existing animal model of depression (intermittent swim stress) and its possible
relationship to anxiety. In the intermittent swim stress (ISS) model, animals
experienced 100, 5 second trials of cold water swim stress, and subsequent
behavioral and cellular mechanisms were assessed. Behavioral measures
incorporated animal models of anxiety (i.e., open field test and juvenile social
exploration), while serotonergic and noradrenergic neurons were assessed at the
dorsal raphe nucleus and locus coeruleus, respectively, through
immunohistochemistry techniques. Results indicated ISS-induced deficits were
noted for social exploration, but not with the open field test. No apparent cellular

differences were revealed following the open field test, but this has yet to be
investigated for juvenile social exploration. The anxiety effects produced by ISS
support the trans-situational value of the model and also suggest ISS as a
possible animal model of post-traumatic stress disorder. Future directions should
assess cellular mechanisms following exposure to juvenile social exploration as
well as explore the time course of the neural activity marker described in the
experiments.

CHAPTER I

INTRODUCTION

Stress is affiliated with a variety of psychological conditions. In particular,
stress is a common risk factor for depression and anxiety (Lapiz-Bluhm, Bondi,
Doyen, Rodriguez, Be'dard-Arana, and Morilak, 2008; Revollo, Qureshi,
Collazos, Valero, & Casas, 2011). Depression is a debilitating disorder that
anyone can experience. An estimated 35 to 40 million Americans, or
approximately 17.6 million Americans each year (Knol, Twisk, Beekman, Heine,
Snoek, & Pouwer, 2006), will suffer from severe depression at some point during
their lives (Kathryn, 2011; Weissmanm & Klerman, 1978). It is anticipated that
this number will continue to climb, as depression is projected to be the second
most disabling condition in the world by 2020 (Mathers, Fat, & Boerma, 2008).
This expectation could be due to the fact that depression has a strong
association with anxiety. The demonstrated correlation between anxiety and
depression has led to the term “anxious depression” (Fava, Rosenbaum, Hoog,
Tepner, Kopp, & Nilsson, 2000; Fava, Rush, Alpert, Balasubramani, Wisniewski,
Carmin, et al., 2008; Fava, Uebelacker, Alpert, Nierenberg, Pava, & Rosenbaum,
1997; Simon, 2009; Van Valkenburg, Akiskal, Puzantian, & Rosenthal, 1984).
Anxious depression is correlated with difficulty in coping, a poorer rate of
recovery (Nelson, 2008), more severe symptoms of depression (Silverstone &
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Salinas, 2001), but, in terms of the rate of relapse, anxious depression is similar
to that of depressed patients without anxiety (Flint & Rifat, 1997).
Fewer than 50 percent of depressed patients experience a complete
recovery using the current treatment methods (Berton & Nestler, 2006). This
lack of effective treatment options is burdensome not only to those who suffer
from depression, but also to those who must care for them (Mathers, Fat, &
Boerma, 2008). As a result, it is critical to have a further understanding of the
neural substrates involved in the comorbidity of depression and anxiety.
Depression
Symptoms. According to the American Psychiatric Association (2000),
major depression is a psychiatric disorder characterized by: depressed mood;
loss of interest in activities; significant change in weight; difficulty sleeping or
thinking; restless activity; low energy; feelings of worthlessness, hopelessness,
or guilt; and recurrent thoughts of death or suicide. These symptoms may be
similar to other psychiatric disorders (e.g., anxiety disorders, bipolar disorder,
and post-traumatic stress disorder). However, major depression can only be
classified as such when several of the above symptoms are persistent for two
weeks or longer, disrupt daily social- or work-related activities, and cannot be
attributed to other causes (e.g., medical conditions such as hypothyroidism) or
disorders. Depression is a common disorder that anyone could be susceptible
to, but people with family members suffering from depression are at a greater risk
of development. The genetic risk is approximately 40-50 percent greater than
people with no family history of depression (Fava & Kendler, 2000; Weissman,
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Wickramaratne, Nomura, Warner, Verdeli, Pilowsky, et al., 2005). Additionally,
environmental factors, such as some form of trauma, disease, or life stress, can
contribute to depression (Fava & Kendler, 2000; Nestler, Barrot, DiLeone, Eisch,
Gold, & Monteggia, 2002); and, in general, women tend to be at a greater risk of
depression (Kessler, McGonagle, Swartz, Blazer, & Nelson, 1993; Wade,
Caimey, & Pevalin, 2002).
Relation to Anxiety. There is a noticeable relationship between
depression and anxiety, as depression is often experienced by anxiety patients
and vice versa. In fact, 62 percent of patients suffering from major depression
also have high levels of anxiety (Boehnlein & Kinzie, 2007). Ultimately, anxiety
and depression share several symptoms such as sleep problems (Eller, Aluoja,
Vasar, & Veldi, 2006), feelings of worthlessness, and cognitive impairments to
name a few — with stress as a common risk factor (Lapiz-Bluhm et al., 2008).
This overlap between anxiety and depression is the result of similarities between
neurobiological mechanisms, and the fact that both may respond to the same
pharmacological treatments (i.e., serotonin- and norepinephrine-based drugs;
Nutt, Ballenger, Sheehan, & Wittchen, 2002).
Neuropsychology of Anxiety. Gray (1982) initially outlined the idea of the
“neuropsychology of anxiety.” The neural and behavioral effects of anxiolytic
drugs in animals can translate to the anxiety experienced by humans. The
behavioral actions of anxiolytic drugs can be depicted through the behavioral
inhibition system. The primary role of the behavioral inhibition system is to
assess risk and increase risk aversion when situations of conflict present
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themselves through a comparator, which compares actual and expected stimuli,
known as the septo-hippocampal system. A conflict may be generated through
signals of punishment, signals of non-reward, or novel or fearful stimuli.
However, the behavioral inhibition system is implemented for resolution of the
conflict to avoid negative or painful outcomes. The septo-hippocampal system is
believed to encode various facets of anxiety. When there is a failure to handle
an expected conflict (e.g., an unpredictable or fearful event) this system will
activate the amygdala to produce a state of anxiety and increase avoidance
tendencies. The administration of anxiolytics can help to resolve the conflict by
modulating behavioral inhibition induced by fear, increasing arousal, and
increasing attention. The septo-hippocampal system is indeed a vital component
of the behavioral inhibition system, as anxiolytics impair the control of theta
activity, the principle response to arousal, in the hippocampus. More importantly,
a lesion to the septal or hippocampal regions leads to a significant reduction in
functioning of the behavioral inhibition system (McNaughton & Gray, 2000).
Neurobioloaical Basis of Anxiety. In terms of the neurological aspects of
anxiety, research has primarily focused on GABAergic, serotonergic, and
noradrenergic neurotransmitter systems playing the most critical roles for
anxiety-related disorders. GABAergic neurons, specifically GABAa receptors, are
widely distributed throughout the brain and are believed to regulate anxiety/fear
responses by inhibiting both the locus coeruleus and raphe nucleus — thereby
suppressing neuronal firing. The locus coeruleus and raphe nucleus are where
the majority of noradrenergic and serotonergic neurons are located, respectively.
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Due to its inhibitory effects, GABA (gamma-aminobutyric acid) acts as a
moderator by suppressing neuronal firing in the locus coeruleus and raphe
nucleus (Dell’Osso, Buoli, Baldwin, & Altamura, 2010).
The noradrenergic neurons in the locus coeruleus project to the forebrain.
Their role in anxiety could also be associated with their connection to stress,
arousal, and fear (Aston-Jones & Cohen, 2005; Aston-Jones, Rajkowski, Kubiak,
Valentino, & Shipley, 1996; Bremner, Kristal, Southwick, & Charney, 1996).
When there is an increase in the production and release of norepinephrine, there
is an elevation in anxiety levels. On the other hand, when neuronal firing in the
locus coeruleus is depleted (Grimsley, 1995) or lesioned (Redmond, 1977;
Redmond, Huang, Synder, & Maas, 1976), there is a significant reduction in
anxiety-fear behavior. As for the serotonergic neurons in the raphe nucleus,
there is a projection to areas throughout the brain such as the limbic system,
hypothalamus, and bed nucleus of stria terminalis (BNST). Moreover, when
there are elevated levels of serotonin, there is also a greater incidence for
anxiety-related disorders (Dell’Osso, Buoli, Baldwin, & Altamura, 2010), and the
serotonergic neurons of the dorsal raphe nucleus (DRN) are known to act as
mediators in stressful situations. In fact, the DRN-BNST pathway is suggested to
be important in mediating anxiety-related behaviors (Commons, Connolley &
Valentino, 2003; Phelix, Liposits & Pauli, 1992).
Corticotropin-releasing factor (CRF) acts as a physiological mediator of
stress-related functions (Hammack, Richey, Schmid, LoPresti, Watkins, & Maier,
2002; Hammack, Schmid, LoPresti, Der-Avakian, Pellymounter, Foster, et al.,
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2003; Price, Kirby, Valentino, & Lucki, 2002; Mo, Feng, Renner, & Forster, 2008;
Rivier & Vale, 1983), as intracerebral administration of CRF yields similar results
produced by stressors (Koob & Heinrichs, 1999). Moreover, blocking the CRF
receptors greatly attenuates the release of serotonin during the stress response
(Hammack et al., 2002, 2003; Price & Lucki, 2001; Mo et al., 2008), and reduces
anxiety behaviors (Deak, Nguyen, Ehriich, Watkins, Spencer, Maier, et al., 1999;
Ising & Holsboer, 2007; Risbrough & Stein, 2006). This is an interesting notion,
because the DRN receives extensive projections from the CRF neurons
(Sakanak, Shibasaki, & Lederis, 1987). As a result, areas containing CRF
receptors have been correlated with anxiety. CRF has two receptor subtypes:
CRF type 1 receptor (CRFi) and CRF type 2 receptor (CRF 2 ). CRF 1 receptors
are mostly located in the amygdala, BNST, cerebral cortex, and brainstem, while
CRF 2 receptors can be found mostly in the amygdala, BNST, lateral septum, and
ventromedial hypothalamus (Chen, Brunson, Muller, Cariaga, & Baram, 2000;
Van Pett, Viau, Bittencourt, Chan, Li, Arias, et al., 2000). The following will
expand more on the roles of serotonin and norepinephrine as well as the brain
areas involved for anxiety/depression.
Serotonin & Neural Innervations. The role of serotonin (5hydroxytryptamine, 5-HT) in anxiety is complex, as it has various receptor
subtypes, which can be located on either the presynaptic or postsynaptic
membranes. These receptors can yield excitatory or inhibitory effects (Hoyer,
Hannon, & Martin, 2002), which is also true of other monoamines (Knapp,
Breese, Mueller, & Breese, 2001). Electrical stimulation of the dorsal
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periaqueductal gray (DPAG) area induces anxious behavior, but stimulation of 5HTia or 5 -HT 2A presynaptic autoreceptors in the DPAG reduces anxiety. This
suggests that the 5-HT nerve fibers in the DPAG may regulate anxiety behavior
(Graeff, 2002). The 5-HT receptor subtypes in the DPAG may have unique
characteristics, as genetic studies with rodents noted that the inactivation of 5HTia (Gross, Zhuang, Stark, Ramboz, Oosting, Kirby, et al., 2002) and 5-HT2a
(Weisstaub, Zhou, Lira, Lambe, Gonzalez-Maeso, Hornung et al., 2006)
postsynaptic receptors led to increased or decreased anxiety, respectively.
Additionally, when 5-HTiA receptors are active in the dentate gyrus of the
hippocampus there is a decrease of anxiety behavior (Tsetsenis, Ma, Lacono,
Beck, & Gross et al., 2007).
With regard to other brain areas associated with 5-HT, the basolateral
amygdala receives serotonergic innervation from the DRN (Hale et al., 2008a;
Fallow & Ciofi, 1992). Furthermore, there is noticeable activation of the
basolateral amygdala when subjected to an anxiety-provoking stimulus (Hale et
al., 2008a; Hale, Hay-Schmidt, Mikkelsen, Poulsen, Shekhar, & Lowry, 2008b).
There is also activation of the 5-HT neurons in the DRN, a significant source of
production of 5-HT in the brain, following anxiogenic or stressful stimuli derived
from drug-induced anxiety (Christianson et al., 2008a) or uncontrollable stress
(Grahn, Will, Hammack, Maswood, McQueen, Watkins, et al., 1999).
5-HT neurons in the DRN are sensitive to pharmacological compounds.
The administration of anxiogenic compounds such as p-carbolines (Christianson,
Paul, Irani, Thompson, Kubala, Yirmiya, et al., 2008a; Abrams, Johnson, Hay-
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Schmidt, Mikkelsen, Shekhar, & Lowry, 2005) that bind to 5 -HT 2A/2 C receptors
(Grella, Teitler, Smith, Herrick-Davis, & Glennona, 2003), inverse
benzodiazepine agonists (Maier, Busch, Maswood, Grahn, & Watkins, 1995a), 5HT2A/2C receptor agonists, and even caffeine administration are associated with
enhanced anxiety levels (Abrams et al., 2005). Whereas, anxiolytics such as 5HTia agonists have been associated with attenuating anxiety levels (Christianson
et al., 2008a). 5 -H T ia agonists such as 8-hydroxy-2-(di-n-propylamino)tetralin (8OH-DPAT), ipsapirone, gepirone, and buspirone work by inhibiting the neuronal
firing of the DRN (Fornal, Litto, Metzler, Marrosu, Tada, & Jacobs, 1994), which
result in the anxiolytic responses (Blier, Pineyro, Dennis, & DeMontigny, 1993).
The activation of the 5-HT neurons in the DRN from an uncontrollable
stressor (e.g., inescapable shock) increases 5-HT levels in the DRN (Maswood,
Barter, Watkins, & Maier, 1998), and also sensitizes these neurons for 24-72
hours. Later stimulation of the 5-HT neurons during further behavioral testing
creates an exaggerated amount of 5-HT that is released in the DRN projection
regions (e.g., areas associated with the limbic system; Amat, Matus-Amat,
Watkins, & Maier, 1998). Inescapable shock (an uncontrollable stressor) seems
to activate the DRN 5-HT neurons to a greater degree than escapable shock (a
controllable stressor) in four w ays:1 DRN lesions (Maier, Grahn, Kalman, Sutton,
Wiertelak, & Watkins, 1993) or otherwise inhibiting the activation of the DRN
(Maier, Grahn, & Watkins, 1995b) prevent inescapable shock-induced deficits,2
Blocking 5 -HT 2 C receptors in projection regions of the DRN (Christianson,
Ragole, Amat, Greenwood, Strong, Paul, et al., 2010) prevent inescapable
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shock-induced deficits, a n d 3 In the absence of any inescapable shock exposure,
pharmacological activation (via p-carbolines) of the DRN 5-HT neurons induces
inescapable shock deficits (Maier et al., 1995a), a n d 4 DRN lesions block the
effects of anxiogenic drugs such as p-carbolines (Hindley, Hobbs, Paterson, &
Roberts, 1985; Maier et al., 1995a). However, the DRN does not appear to be
associated with the process of stress controllability or coping. Controllability
(escapable shock) is believed to be regulated by the ventromedial prefrontal
cortex (vmPFC; Amat, Baratta, Paul, Bland, Watkins, & Maier, 2005).
When the vmPFC is activated or inactivated during inescapable shock, it
either prevents or facilitates, respectively, inescapable shock-induced deficits.
The above observations indicate that the activation of the vmPFC is critical for
the protective effects of controllability of electric shock (Amat et al., 2005; Amat,
Paul, Watkins, & Maier, 2008). Furthermore, vmPFC plays a significant role in
regulating the activity of the amygdala, a brain area known for emotion regulation
such as anxiety (Jovanovic & Ressler, 2010). For people suffering from an
anxiety disorder, such as post-traumatic stress disorder, higher levels of activity
in the vmPFC correlate to higher levels of anxiety (Koenigs et al., 2008). In
general, there appears to be mixed results for the role of the vmPFC with regard
to the stress response (i.e., glucocorticoid release), as activity in the vmPFC has
been shown to inhibit as well as enhance glucocorticoid release (Myers-Schulz &
Koenigs, 2011), which could be due to the prelimbic and infralimbic subregions of
the vmPFC (Baratta, Zarza, Gomez, Campeau, Watkins, & Maier, 2009).
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Norepinephrine & Neural Innervations. Norepinephrine also plays a
significant role in anxiety, as noradrenergic neurons in the LC project to a variety
of areas throughout the brain (e.g., cerebellum, hypothalamus, amygdala,
hippocampus, prefrontal cortex; Bishop, 2007). Exposure to different stressors
(e.g., electric shock or conditioned fear) results in increased production of
norepinephrine in the LC (Pacak & Palkovits, 2001), but activity in the LC does
not appear to be dependent upon stressor controllability (McDevitt et al., 2009).
Stress exposure also results in norepinephrine increases in the amygdala,
hippocampus, and hypothalamus (specifically in the paraventricular nucleus;
Pacak & Palkovits, 2001). The increase of norepinephrine in the paraventricular
nucleus of the hypothalamus activates the sympathetic nervous system and the
hypothalamic-pituitary-adrenal (HPA) axis. This increases the release of
glucocorticoids and adrenalin (or epinephrine), which can also result in increased
anxiety behaviors (Koob, 1999).
Electrical stimulation of the LC induces anxiety, while lesioning this region
prevents anxiety symptoms (Redmond, 1977; Redmond, Huang, Synder, &
Maas, 1976). Within the LC, norepinephrine effects tend to be mediated through
the presynaptic alpha-2 receptors and postsynaptic alpha-1 and beta-1 receptors.
When targeting the alpha-2 autoreceptor via an alpha-2 adrenergic antagonist,
yohimbine, there is an increase in production in norepinephrine from the LC.
This, in turn, facilitates symptoms of anxiety (Grimsley, 1995). However, an
alpha-2 adrenergic agonist, clonidine, has been shown to inhibit functioning of
the LC with the dose playing a vital role. These effects tend to be caused by
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lower doses acting on presynaptic (alpha-2) autoreceptors (Solanto, 1998), and
the diminished production of norepinephrine will thereby attenuate anxiety levels
(Grimsley, 1995). Higher doses of clonidine are believed to act on postsynaptic
receptors, are ineffective at inhibiting norepinephrine, and actually foster the
release of norepinephrine (Ramos and Arnsten, 2007).
Traumatic stress such as some anxiety disorders (i.e., post-traumatic
stress disorder) results in an exaggerated production and release of
norepinephrine (Strawn & Geracioti, 2008). However, depression is not directly
caused by either an increase or decrease of norepinephrine in the brain, as
norepinephrine’s more critical role is to act as a moderator for major inhibitory or
excitatory neurotransmitters (e.g., gamma-aminobutyric acid and glutamate;
Anand & Chamey, 2007).
Serotonin & Norepinephrine Interaction. 5-HT and norepinephrine have a
significant relationship with each other, as 5-HT projects to norepinephrine
neurons and vice versa. Moreover, the projections of 5-HT neurons to
norepinephrine neurons appear to be inhibitory. When there is a significant
lesion of 5-HT neurons, the firing rate of norepinephrine neurons increase to
approximately 70 percent above baseline in the locus coeruleus (Dremencov, El
Mansari, & Blier, 2007). 5-HT’s inhibitory nature on norepinephrine is further
confirmed by depleting the availability of norepinephrine and administering
selective-serotonin reuptake inhibitors (SSRIs). Inhibition of norepinephrine
neurons via systemic administration substantially diminishes the rate of neuronal
discharge for 5-HT in the DRN for the first few days (Svensson, Bunney, &
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Aghajanian, 1975). Prolonged exposure to SSRI treatment has demonstrated a
considerable decrease in the firing rate from norepinephrine neurons over a
longer period of time (Blier, 2001).
Mirtazapine, which provides treatment for anxiety and depression, acts as
an antagonist at both the 5 -H T 2a/2c and norepinephrine alpha-2 receptors
(Kooyman, Zwart, Vanderheijden, Van Hooft, & Vijverberg, 1994; Millan, Gobert,
Rivet, Adhumeau-Auclair, Cussac, Newman-Tancredi, et al., 2000). Chronic
treatment with mirtazapine will cause an increase in the production of both 5-HT
and norepinephrine; a smaller increase for norepinephrine and a more prominent
increase for 5-HT, However, when the norepinephrine neurons are lesioned in
the LC, the increase in the 5-HT activity produced by mirtazapine is no longer
apparent (Blier, 2001). Furthermore, projections of norepinephrine neurons to 5HT neurons tend to enhance the regeneration of serotonergic axons (Liu &
Nakamura, 2006) suggesting an excitatory pathway. Ressler and Nemeroff
(2000) have even suggested that there are both excitatory and inhibitory
projections from the LC to DRN.
When selecting an antidepressant drug, for treatment of depression or an
anxiety disorder, it is important to understand the functioning of both the 5-HT
and norepinephrine systems. The effectiveness of antidepressants is thought to
be due to a prolonged increase in the availability of the neurotransmitter at the
synapse, which will decrease the number of receptors on the postsynaptic
terminal (also known as down-regulation; Norman, 1999), as well as increases in
brain-derived neurotrophic factor (BDNF) expressions and subsequent
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neurogenesis in the brain (Jacobs, van Praag, & Gage, 2000; Malberg, Eisch,
Nestler, & Duman, 2000). Additionally, in terms of more effective therapeutic
treatment, if there is a deficiency in one neural system (i.e., 5-HT or
norepinephrine) at times it may be more beneficial to treat the other system to
reach the desired end result. In fact, depression that is associated with 5-HT
depletion can be alleviated by enhancing the availability of norepinephrine. The
cause of depression is far more complex than just focusing on the fluctuations of
only 5-HT or norepinephrine levels. Dysfunctions in the brain associated with
depression as well as anxiety disorders are likely modulated by different
monoamine systems (Delgado, 2006; Delgado & Moreno, 2000). In an effort to
investigate 5-HT or norepinephrine changes, in particular anatomical regions
following exposure to a stressful stimulus, a variety of methods have been
implemented (e.g., micro dialysis, autoradiography, or c-Fos). However, c-Fos is
ideal because it allows an isolation of an anatomical area of interest.
c-Fos Immunohistochemistrv. c-Fos is the protein product of an
immediate early gene, and is a marker of neuronal activation. Following
exposure to anxiogenic (e.g., p-carboline) or stressful stimuli, c-Fos is expressed
in the DPAG (Lino-de-Oliveira, de Oliveira, Padua Carobrez, de Lima, del Bel, &
Guimaraes, 2006), basolateral amygdala (Knapska, Radwanska, Werka, &
Kaczmarek, 2007), DRN (Amat et al., 2005), prelimbic and infralimbic
subregions of the vmPFC (Baratta et al., 2009), and LC (Webb, Patton, Landry,
Mistlberger, 2010). The double-immunostaining protocol for c-Fos is an ideal
technique for identifying which class of neurons is active, thereby allowing us to
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investigate the 5-HT and norepinephrine systems. It is advantageous because it
can provide greater clarity to different aspects of the cell (i.e., shape, size, and
orientation of dendrites), which is not possible using the nuclear, Fos
immunoreactivity technique (Peng, Chen, & Bentivoglio, 1995).
Animal Models of Depression
Use of Animal Models. Animal models are critical to understanding the
various components of depression and to allow insight into novel drug discovery.
Pre-clinical experiments allow researchers to have complete control over the
experimental parameters of the subject (e.g., age, experiential history, sex,
weight, food-intake, and environment), which can be quite difficult to accomplish
in human models. Additionally, animal models have the potential to provide
ground-breaking results, and can establish unequivocal cause-and-effect
relationships. While research has been conducted on a variety of animals, rats
have been a reliable and extensively used subject. The rat is an ideal animal
specimen because its anatomical and physiological features parallel those of
humans. However, one might wonder how depression can be elicited and
objectively measured in animals?
Experimentally simulating depression has been discussed in great detail,
as various authors have considered the advantages and disadvantages of animal
models (Cryan, Markou, & Lucki, 2002; Henn, Edwards, & Muneyyirci, 1993;
Porsolt, 2000). Ultimately, most authors accept a set of criteria devised by
Mckinney and Bunney (1969). These guidelines indicate that the animal model
includes: comparable symptoms to those experienced by humans; behavioral
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endpoints that can be measured in an objective manner; induced depression to
be remedied by treatments that could potentially be effective for humans (e.g.,
antidepressants); and procedures and results that can be replicated by other
researchers.
A limitation of animal models is that it is difficult to examine all of the
symptoms identified by the American Psychiatric Association (2000) in the
diagnostic criteria of major depression. In particular, symptoms such as
depressed mood, feelings of worthlessness, hopelessness, or guilt, and recurrent
thoughts of death or suicide are impossible to evaluate — researchers cannot
access what the animal is thinking during behavioral testing. However, through
behavioral endpoints, it is possible to monitor other depressive behaviors such as
anhedonia or low energy, significant change in weight, difficulty sleeping,
cognitive impairments, social interaction deficits, and restless activity.
Forced-swim test. One of the most widely used models for screening
novel antidepressants is the forced-swim test (FST), also known as the
behavioral despair test (Porsolt et al., 1977). In this model, rats are placed in a
cylinder filled with water. The rat is unable to make contact with the bottom of the
cylinder with its feet (Borsini, Volterra, & Meli, 1986; Drugan, Skolnick, Paul, &
Crawley, 1989), which forces the animal to swim. The rat swims in the apparatus
for 15 minutes during the first session, and then 24 hours later the rat is forced to
swim again for only 5 minutes. During the time spent in the cylinder on the
second day, three distinct patterns of behavior are noted by the animal in the
modified FST (Detke et al., 1995): swimming, climbing, and immobility (floating).
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The behavioral pattern of immobility is of greatest interest, as this is a sign of
behavioral depression in the animal. Researchers have questioned whether the
rat is truly experiencing depression when the rat is immobile. Some tend to
believe the immobile behavior expressed by the rat is rather a “functionally
adaptive strategy” to cope with the inescapable stressor (Nishimura, Tsuda,
Oguchi, Ida, & Tanaka, 1988). However, when rats are administered
antidepressants they emerge from the immobile state to an active state of
increased swimming or climbing based on the type of antidepressant given
(Christianson, Rabbett, Lyckland, & Drugan, 2008; Detke, Rickels, & Lucki, 1995;
Drugan, Macomber, & Warner, 2010; Lucki, 1997). Moreover, antidepressant
drugs reverse immobility in rats selectively bred for low activity in the swim test
(Weiss, Cierpial, & West, 1998; West & Weiss, 1998). The effect is not a result
of general activation, as antidepressant-treated rats subsequently placed in an
open field test do not show hyperactivity (Porsolt, Anton, Blavet, & Jalfre, 1978).
Learned Helplessness. Another widely used model of depression is that
of inescapable shock/learned helplessness (Maier & Seligman, 1976; Henn et al.,
1993; Weiss, Goodman, Losito, Corrigan, Charry, & Bailey, 1981). This
phenomenon was first demonstrated with dogs exposed to inescapable electric
shocks. The shocks interfered with the dogs’ ability to escape in a shuttle-box
task (Overmier & Seligman, 1967; Seligman & Maier, 1967). Soon after,
researchers began testing the effects of learned helplessness on rats and noting
similar results (Maier, Albin, & Testa, 1973; Weiss & Glazer, 1975). Although
learned helplessness has been examined in numerous different species, the
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process of its examination has remained largely consistent. The typical format
for investigating this concept includes three animals that will be used at a time,
following a triadic design, with two of the three animals receiving intermittent
electric shocks and the third serving as the restrained control (therefore receiving
no shock). Of the two animals being shocked, one animal has the opportunity to
terminate the shock (escape), for both itself and the yoked-inescapable shock
subject; typically accomplished by the animal pressing a lever or turning a wheel.
The other animal will be shocked regardless of its actions (yoked), and thus, the
highly stressful scenario of inescapable shock is created. After being exposed to
inescapable shock, research has demonstrated that the animal does not attempt
to avoid or escape the shocks if given the opportunity to escape. This behavioral
outcome is indicative of that animal experiencing “learned helplessness” (Maier &
Seligman, 1976). Animals exposed to inescapable, but not escapable, shock
have exhibited other behavioral and physiological changes in addition to
behavioral depression, including: “freezing behavior,” which is an expression of
fear (Maier, 1990), opioid-mediated stress-induced analgesia (Drugan, Ader, &
Maier, 1985), anorexia (Dess, Choe, & Minor, 1998), learning deficits (Seligman
& Maier, 1967), lower activity levels (Desan, Silbert, & Maier, 1988; Drugan &
Maier, 1983), reduced food competition dominance (Rapaport & Maier, 1978),
changes in conditioned place preference for drugs of abuse (Rozeske, DerAvakian, Bland, Beckley, Watkins, & Maier, 2009), and anhedonia (Dess, Minor,
& Brewer, 1989).
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Learned helplessness may result from serotonergic activation (Amat et al.,
1998) and noradrenergic inactivation. Specifically, in the dorsal raphe nucleus
(Amat, Tamblyn, Paul, Bland, Amat, Foster, et al., 2004; Grahn et al., 1999;
Maier and Watkins, 2005) and the locus coeruleus, respectively, as inescapable
shock produces large increases in 5-HT (Amat et al., 1998) and decreases in
norepinephrine (Weiss & Simson, 1986). Animals that are able to cope with the
effects of stress (escape from the shock) do not display depleted levels of
norepinephrine (Weiss et al., 1970; Weiss et al., 1981), nor do they show the
sensitization of the DRN (Rozeske, Evans, Frank, Watkins, Lowry, & Maier,
2011) in comparison to yoked rats. On a pharmacological level, drugs that
enhance the release of norepinephrine combat the effect of learned helplessness
(Sherman et al., 1982), while drugs that actively deplete levels of norepinephrine
produce many behavioral deficits comparable to learned helplessness (Anisman,
Remington, & Sklar, 1979). Other studies have produced similar results when
norepinephrine levels were enhanced (Petty, Kramer, Wilson, & Chae, 1993;
Sherman & Petty, 1980). In terms of the role of 5-HT-based drugs, the
administration of a 5-HT agonist in the DRN blocks the effects of inescapable
shock (Maier et al., 1995b).
Intermittent Swim Stress (ISSL ISS has a component of learned
helplessness, as it uses intermittent, inescapable stress exposure, and also a
component of behavioral despair (or FST) by using water as the stressor. Water
is a predominant part of the environment for many animals, and is a naturally
occurring stressor for rats in comparison to the shock or restraint stress

18

mentioned previously (Russell, Towns, Anderson, & Clout, 2005). ISS is an
effective stressor to induce behavioral depression such as enhanced immobility
in the FST, interference with instrumental swim escape performance
(Christianson & Drugan, 2005; Christianson et al., 2008b; Drugan, Macomber, &
Warner, 2010), as well as increased latency to escape in the Morris water maze
(MWM; Warner & Drugan, 2012). Unlike inescapable shock and continuous
swim stress, or stressors that are sensitive to both acute SSRIs and
norepinephrine selective reuptake inhibitors (NSRIs; Detke et al.,1995; Drugan et
al., 2010; Maier & Watkins, 2005), ISS effects are sensitive to NSRI yet resistant
to a variety of serotonergic manipulations — including SSRIs (Christianson et al.,
2008b; Drugan et al., 2010). This difference suggests that the ISS effects are
mediated by distinct neural systems that may lead to new insights into stressrelated pathology and hasten novel drug discovery.
Resemine-lnduced Depression. This is considered as a pharmacologicalbased animal model of depression. Of the various pharmacological agents, the
administration of reserpine, in particular, elicits signs of depression due to its
depletion of monoamines. The importance of monoamines can be explained by
the monoamine hypothesis, which is a controversial idea that depression is the
result of the underactivity of the monoamines in the brain (Baumeister, Hawkins,
& Uzelac, 2003).
Olfactory Bulbectomv. For this animal model, the olfactory bulb is
surgically removed. While it is not clear how this procedure translates to
depression, it has been suggested that the chronic sensory disruption
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experienced by the animals can act as an intense, stressful experience (O’Neil &
Moore, 2003)
Congenital Learned Helplessness. This is a genetic animal model of
depression that incorporates selective breeding. In this model, rats are bred to
be more or less prone to the effects of learned helplessness, (i.e., shuttlebox
escape deficits) and thereby creating two categories of rats: congenitally learned
helplessness and congenitally not learned helpless. For the congenital learned
helpless group, these rats express a helpless phenotype even during escapable
shock. For the non-congenital group, this strain of rats is resistant to the effects
of learned helplessness even during inescapable shock (Henn & Vollmayr,
2005).
Flinders Sensitive Line Rats. Another genetic animal model of
depression, these rats are selectively bred to be more sensitive to cholinergic
agonists (acetylcholine). This paradigm parallels the cholinergic hypersensitivity
experienced by depressed patients (Overstreet, Friedman, Mathe, & Yadid,
2005) who experience a heightened sensitivity to cholinergic agonists compared
to normal controls (Janowsky, Overstreet, & Numberger, 1994; Risch, Kalin, &
Janowsky, 1981).
Animal Models of Anxiety
In pre-clinical models of anxiety, the goal is to mirror the same symptoms,
behavioral responses, biological mechanisms, and response to pharmacological
treatments to those of human anxiety (Ramos, 2008). While there are genetic
strains of anxious rats such as the Maudsley reactive rat (Broadhurst, 1960),
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research predominately focuses on conditioned and unconditioned animal
models of anxiety. Described below are samples of such models.
Conditioned Animal Models of Anxiety
Fear-Potentiated Startle. In this model, an animal will associate a neutral
stimulus (e.g., a light), with an aversive stimuli (e.g., electric shock). Following
exposure, the animal will then be presented with an intense sound, which will
produce a startle response. This startle response is potentiated with the
additional presentation of the formerly neutral, but now conditioned, stimulus.
There are a variety of drugs that reduce fear-potentiated startle in rats such as
alpha-2 adrenergic agonists (e.g., clonidine), opioid receptor agonists (e.g.,
morphine), benzodiazepine/GABAA agonists (e.g., diazepam; Davis, Falls,
Campeau, & Kim, 1993), and selective 5 -H T ia receptor agonists (e.g., busiprone;
Kehne, Cassella, & Davis, 1988). This type of cue-dependent fear has been
reported to be exclusively reliant on the amygdala (Rogan & LeDoux, 1996), as
NMDA (A/-methyl-D-aspartate) antagonists, a type of glutamate receptor, injected
into the amygdala extinguish fear-potentiated startle (Falls, Miserendino, & Davis,
1992; Miserendino, Sananes, Melia, & Davis, 1990).
Contextual Fear. The rat will experience an aversive stimulus (e.g.,
electric shock), but will not be exposed to a novel or cued stimulus. Later the rat
will be placed back in the same context to assess if re-exposure to the same
environment without the aversive stimulus will elicit fear (Luyten,
Vansteenwegen, van Kuyck, Gabriels, & Nuttin, 2011). SSRIs, 5-HT i A receptor
agonists (Inoue, Kitaichi, & Koyama, 2011) as well benzodiazepines (Harris &
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Westbrook, 2001) that act to enhance the inhibitory effects of GABA (Haefely,
1990), attenuate the symptoms associated with contextual fear. Lesioning of the
amygdala, hippocampus, or periaqueductal gray results in varying anxiety levels
determined by the animals’ “freezing” behavior. Inactivation of the amygdala and
ventral, but not dorsal, periaqueductal gray reveal a reduction in freezing (or
lower anxiety levels), whereas inactivation of the hippocampus produces a robust
level of freezing only initially that is no longer apparent 24 hours later. This
indicates there are both short- and long-term conditioned fear states (Kim, Rison,
& Fanselow, 1993). Moreover, depleting the stress horomone (corticosterone)
via an adrenalectomy in rats does not eliminate a contextual fear conditioning
response immediately, but an alleviation of fear is noted 24 hours later (Pugh,
Tremblay, Fleshner, & Rudy, 1997).
Voael Thirst-Lick Conflict Test. For this apparatus, water-deprived
animals are given a reward of water while simultaneously receiving an electric
shock to the tongue on every 21st lick. Animals that receive anxiolytics will
continue consuming the water. However, control animals (who receive no drugs)
will avoid the aversive stimulus (Bourin, Petit-Demouliere, Dhonnchadha, &
Hascoet, 2007). Benzodiazepines have been reliable anxiolytics for either male
or females, whereas in some pharmaceuticals such as SSRIs, e.g., fluoxetine,
are effective in producing anxiolytic-like effects, only in male rats. It has also
been suggested that the serotonergic activity in the dorsal hippocampus
mediates this conflict behavior (Matsuo, Kataoka, Mataki, Kato, & Oi, 1996).
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Geller-Seifter Test. For the rat, a positive reinforcer (such as food) is
obtained by performing an instrumental response (i.e., lever pressing). After the
rat reaches a point where it is making consistent operant responses for the
positive reinforcer, approximately seven trials later a negative reinforcer (i.e.,
electric shock) is added. The presentation of the positive reinforcer is
simultaneously paired with electric shock to the rat, and, thus, creating a conflict
between the positive and negative reinforcement (Geller, Kulak, & Seifter, 1962).
5 -HT 2C receptor

antagonists (Kennett, Pittaway, & Blackburn, 1994) and

benzodiazepines (Geller, Kulak, & Seifter, 1962) have shown anxiolytic
properties, and encouraged rats to tolerate more shocks to obtain more food.
Furthermore, a serotonergic antagonist injected into the basolateral amygdala
results in anxiogenic effects for this particular conflict paradigm (Hodges, Green,
& Glenn, 1987).
Defensive Burying Test. The rat will be placed in a cage filled with
sawdust bedding where the rat will receive an electric shock from a stationary
electrified prod. Typically, after receiving a shock, the rat will exhibit a passive
behavioral response (i.e., inactivity) followed by a vigorous burying behavior to
move the sawdust bedding onto and subsequently covering the electrified prod.
This defensive burying is only seen when a shock is administered, so it does not
occur in the absence of shock (Pinel & Treit, 1978; Treit, Pinel, & Fibiger, 1981).
Benzodiazepines have been effective in reducing the defensive burying behavior
(Treit, 1990; Treit et al., 1981). Furthermore, lesions to either the dorsal
premammillary nucleus, anterior hypothalamus, or the dorsal medial portion of
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the ventromedial hypothalamus suppress unconditioned defensive behaviors
(Canteras, 2002; Canteras & Swanson, 1992; Risold, Canteras, & Swanson,
1994).
Unconditioned Animal Models of Anxiety
Elevated-Plus Maze. The elevated-plus maze is an effective animal
model of anxiety. The design of this maze is an elevated platform with four arms.
Two of the arms have surrounding walls, while the other two arms are open and
without walls. The arms are interconnected by a central platform. Time spent
navigating the maze, and the number of entrances in the open arms, are
commonly used as measures of anxiety because of rats’ innate fear of novel,
open spaces; while time spent in the closed arms is assessed as a measure of
general motor activity (Ramos, 2008). SSRIs tend to induce, rather than
ameliorate, behavior indicative of anxiety (Takeuchi, Owa, Nishino, & Kamei,
2010). Furthermore, the performance of rats in the elevated-plus maze is
unaltered by norepinephrine-based drugs (i.e., desipramine; Drapier, BentueFerrer, Laviolle, Millet, Allain, Bourin, et al., 2007), however, serotoninnorepinephrine reuptake inhibitors (SNRIs) have produced results comparable to
anxiolytic compounds, such as benzodiazepines (Takeuchi, Owa, Nishino,
Kamei, 2010).
Liaht-Dark Box. The light-dark box consists of two areas. The larger area
has a white and brightly lit background, while the smaller area has a dark and
black background. Exploration in the larger, illuminated white background is
used as the measurement of anxiety (due to a rat’s innate fear of exposure to
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bright light; anti-phototropic). The assessment of anxiety is based on the time
spent in the area, motor activity, and number of entries (Crawley & Goodwin,
1981; Ramos, 2008). On a similar note to the elevated-plus maze, SSRIs are
generally inactive in reducing anxiety and actually facilitate anxiogenic-like
responses (Bodnoff, Suranyi-Cadotte, Quirion, & Meaney, 1989).
Benzodiazepines, which are typically effective in reducing anxiety, do not have
an impact in the light-dark box for rats, but do show anxiolytic properties for mice
(Ramos, Pereira, Martins, Wehrmeister, &lzidio, 2008). The alpha-2 adrenergic
antagonist (yohimbine) exerts anxiogenic effects in the light-dark box
(Fernandez, Misilmeri, Felger, & Devine, 2004). In general, the light-dark box is
likely not a reliable marker for screening anxiolytic compounds in rats (Ramos et
al., 2008).
Holeboard Test. Rats are placed in a wooden box with four smaller holes
located in the floor. Infrared photocells are placed on the sides of the box to
detect locomotor activity and rearing. Photocells are also distributed below the
surface of the holes to measure the frequency and duration of head-dips by the
rat. Changes in head-dipping by rodents are believed to be a marker of anxiety,
as increased head-dipping is considered an exploratory behavior that the rats
would perform during less anxious states (File & Pellow, 1985; Takeda, Tsuji, &
Matsumiya, 1998). Benzodiazepines have produced a significant increase in
such exploratory behavior (File & Pellow, 1985). SSRIs and SNRIs have been
advantageous in exhibiting anxiolytic properties in the hole board test (Ishizuka,
Abe, Tanoue, Kannan, & Ishida, 2010).
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Novelty-Suppressed Feeding Test. In this animal mpdel, rats are foed
deprived (not water-deprived) for 48hrs, and then placed in a novel environment
with food where the latency to begin eating is recorded (Bodnoff, SuranyiCadotte, Aitken, Quirion, & Meaney, 1988; Bodnoff et al., 1989).
Benzodiazepines are effective anxiolytics (i.e., reduce latency to eat the food),
whereas either a NSRI or SNRI is not nearly as effective (Bodnoff et al., 1988).
Adult Social Interaction Test. Two adult male rats are placed in the same
environment and the interaction between the rats (e.g., sniffing, following, or
grooming the other rat) is scored. Importantly, only one score for the pair of rats
is used, as the behavior of one rat influences the behavior of the other.
However, if only one rat is treated (e.g., drug administration), then only that rat is
scored. Animals that engage in more social interaction are less anxious, while
decreased social interaction would illustrate the opposite effect. The highest rate
of social interaction occurs between animals in a familiar environment with
minimal lighting (File & Seth, 2003). Benzodiazepines have been effective in
attenuating anxiety in this model (File & Pellow, 1984), whereas benzodiazepine
receptor antagonists exhibit anxiogenic effects (File, Lister, & Nutt, 1982).
Antidepressant drugs (e.g., SSRIs or tricyclic antidepressants) have been
reported to have anxiogenic rather than anxiolytic responses (Bagdy, Graf,
Anheuer, Modos, & Kantor, 2001; To, Anheuer, & Bagdy, 1999; To & Bagdy,
1999).
Juvenile Social Exploration Test. This test is similar to the adult social
interaction test, but a key difference being the utilization of juvenile rats (28-32
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days old). In this model, 24hr before the administration of a stressor (e.g.,
electric shock), the rat is taken from the vivarium and placed in a plastic tub cage
with bedding that is free of food and water. The rat is given 60 min to become
acclimated to the novel environment, then a juvenile rat is placed in the cage with
the adult rat where the researcher will record exploratory behaviors exhibited by
the adult rat (e.g., sniffing, pinning, or grooming the juvenile). Additionally,
behavior is only recorded for the one adult rat in the tub cage. After a few
minutes the juvenile is removed, and the adult rat is returned to its home cage.
This initial social exploration (SE) test is used as a baseline procedure to screen
for rats with any abnormal responses prior to the stressor, as non-stressed rats
will spend a significant portion of time exploring a juvenile. Following the
preliminary screening step, the adult male will be tested again for SE at a later
time point post-stressor (Christianson et al., 2008a). This procedure is slightly
modified from other versions of SE (Bluthe, Dantzer, & Kelley, 1992; Poliak,
Orion, Goshen, Ovadia, & Yirmiya, 2000;Pollak, Ovadia, Goshen, Gurevich,
Monsa, Avitsur, et al., 2000; Poliak, Ovadia, Orion, & Yirmiya, 2003). It has been
illustrated as a successful animal model of anxiety, as the administration of an
anxiogenic (e.g., p-carbolines) or anxiolytic (e.g., benzodiazepines) compound
resulted in either reduced or increased SE, respectively (Christianson et al.,
2008a).
This animal model of anxiety has three distinct advantages over adult
social interaction: 1 The juvenile test takes place in a familiar tub cage, so the
anxiety experienced by the adult rats is not due to novelty.2 Aggressive behavior
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is a far less common interaction with a juvenile compared to another adult rat
(Blanchard, Wall, & Blanchard, 2003) leading to a clearer representation of
anxiety.3 Typically in adult social interaction, the total amount of interaction time
is involved with paired scoring for both adult rats, and, thus, requiring twice the
number of rats and treatments to achieve the same statistical results.
Open Field Test. The open field test (Hall, 1934; Hall & Ballechey, 1932)
is a widely adopted animal model of anxiety for rodents that typically utilizes an
open-top square box (Belzung & Griebel, 2001; Prut & Belzung, 2003). When
rats are experiencing anxiety, they do not explore new environments and hug the
walls of the open field (a behavior known as thigmotaxis). The anxiety-related
behavior is measured by the degree to which the rat avoids the center of the
open field test (Christianson & Drugan, 2005; Walsh & Cummins, 1976).
Behavioral responses in the open field can reveal signs of increased or
attenuated anxiety levels when anxiolytic drugs (such as benzodiazepines and
GABAa agonists; Prut & Belzung, 2003) and 5 -H T ia agonists, respectively,
(Siemiatkowski, Sienkiewicz-Jarosz, Czlonkowska, Bidzinski, & Plaznik, 2000)
are administered. However, behavioral measures are non-responsive to SSRIs
(Durand, Berton, Aguerre, Edno, Combourieu, Mormede et al., 1999). Due to
these tendencies, the open field test does appear to be a representative model of
normal anxiety (i.e., similar to a daily stressor), but may not be representative of
pathological anxiety associated with various anxiety disorders (Prut & Belzung,
2003).
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All of these tests rely on the unconditioned avoidance of a threatening
situation. Moreover, they all measure the conflict a rat has in the desire to
explore new places, but also its natural fear of brightly lit or novel areas (i.e.
neophobia). While all of the animal models would potentially be an effective
measure of anxiety, the open field test is ideal in order to compare its effects to
past work in our laboratory (Christianson et al., 2008b).
Specific Aims
Inescapable shock has been correlated with c-Fos expression in the DRN
(Amat et al., 2005) and LC. However, exposure to either inescapable shock or
escapable shock in the LC, while both producing elevated levels of c-Fos
expression, shows no difference in the amount of c-Fos expressed. This
suggests that the LC is not sensitive to stressor controllability for electric shock
(McDevitt et al., 2009). Exposure to ISS is suggested to activate neural
substrates differently compared to electric shock (Drugan et al., 2010; Warner &
Drugan, 2012). Generally, the ISS model tends to be unresponsive to various 5HT manipulations and 5-HT-based antidepressants (Christanson et al., 2008b;
Drugan et al., 2010), while norepinephrine-based antidepressants have had
favorable results in alleviating ISS-induced deficits (Drugan et al., 2010; Warner
& Drugan, 2012).
The following experiments will explore the implications of serotonergic and
noradrenergic neurons in the DRN and LC, respectively, following ISS exposure
and its possible association with anxiety. The effects of ISS will also be
evaluated, behaviorally, with two animal models of anxiety (i.e., open field test
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and SE). Experiment 1 used double-labeled TPH and TH/c-Fos
immunohistochemistry (IHC) in the brain to detect the neural activity in the DRN
and LC, as well as the open field test to monitor anxiety behavior. However,
increased anxiety-like behavior was not depicted with the behavioral analysis
from the open field data. As a result, experiments 2 and 3 will address the same
concerns as the preceding experiment, but will investigate a different behavioral
endpoint for anxiety (i.e., SE) with experiment 2 being a preliminary experiment
exploring the optimal time post-ISS to evaluate SE.
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CHAPTER II

EXPERIMENT ONE

Method
Subjects
48 male Sprague-Dawley rats (SAS Derived, Charles River Labs, NY,
USA) each weighing between 180-200 grams were used in the experiment. For
the first week, animals were allowed the allotted time to acclimate to the
vivarium. During that time the rodents were housed four to a cage, while food
and water was provided ab libitum. The vivarium was maintained on a 12-hour
light/dark cycle (6:00am to 6:00pm) with the light cycle beginning at 6:00am. All
procedures were conducted during the first 6 hours of the light cycle. After the
first day of procedures, animals were individually housed in tub cages and given
food and water ab libitum. In addition, all procedures were reviewed and
approved by the University of New Hampshire Institutional Animal Care and Use
Committee (IACUC; APPENDIX A).
Apparatus
Intermittent Swim Stress. ISS was conducted in two Plexiglas cylinders
(21cm diameter X 42cm height) with a !4-inch galvanized wire mesh at the
bottom of each cylinder that was suspended over a tank (28.6cm height, 80.6cm
length, and 45.7cm width). The tank was filled with water that reached a depth of
20cm, with the water maintaining a temperature of 15±1°C (ice was consistently
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added to ensure that the temperature remained constant). During the ISS
treatment, a rat was placed in each cylinder and both cylinders were lowered
(simultaneously) into the cold water where the rats were forced to swim. The
cylinders remained in the water for 5 seconds, and then retracted to their original
placement (12.7cm above the water). Over the duration of ISS, space heaters
(two above and two in front of each cylinder) blew warm air (~36°C) to keep the
rats warm in between swim trials. The swim stress apparatus was monitored by
the means of a computer with med-PC hardware and software that controlled the
movement of the cylinders on a variable interval-60sec schedule (Christianson &
Drugan, 2005).
Open field Test. Open field tests were conducted in an open-top square
plywood box (25cm height, 120cm length, and 120cm width) painted with flat
black enamel. A cool white fluorescent lamp emitted 200-300 lux throughout the
box. Open field test sessions were recorded with a video camera located directly
over the center of the arena.
Procedure
On the first day of experimentation, rats were randomly assigned to one of
six conditions: home cage control (HCC)/open field, confined control (CC)/open
field, ISS/open field, HCC/HCC, CC/HCC, or ISS/HCC with 8 rats/group. ISS
rats were exposed to 100-5sec forced swims in the cold water (15°C) on a
variable interval (Vl)-60sec schedule (range = 10 - 100sec) in a procedure that
we have shown to produce behavioral depression (Christianson & Drugan,
2005). CC rats were placed in the same apparatus and put through the same
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intermittent procedure, but in the absence of water. After being exposed to the
swim stress, ISS rats were warmed under incandescent lamps (75W just above
the cage top) for 30 min while CC rats were placed under lamps positioned 90cm
above the cage to control for light exposure. Following the warming period, all
rats were returned to the vivarium. The HCC rats were never exposed to the ISS
apparatus to ensure that the CC animals were a reliable control group.
On day two, depending on the condition, rats would either experience the
open field test or remain in the vivarium as a HCC. Rats were placed in the open
field test for 10 min with the each rat initially being placed in the center of the
open field arena. The frequency of the following behaviors was recorded:
grooming (using paws or tongue to clean itself), rearing (standing on hind legs),
and corner facing (time spent facing a comer of the box). Time spent in the outer
and inner sections of the arena was recorded. The outer section of the box was
defined as all of the squares on perimeter of the walls, which included the four
comers (i.e., 20 of 36 squares). The remaining region of the arena (16 squares)
was defined as the inner section or center. Locomotor activity was recorded as
number of line crossings (all four paws crossing a line; Hale et al., 2008a). The
experimenters making the behavioral assessments were blind to group
membership.
Tissue Collection and Preparation
90 min after the behavioral testing (e.g., open field test) rats were
perfused (Sartor & Aston-Jones, 2012). Prior to perfusions, all rats were injected
with a mixture of 80 mg/kg of ketamine and 8 mg/kg xlyazine of the animal’s body
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weight for the anesthetic. The researcher would pinch a paw of the animal firmly
to ensure there was no longer a pain reflex for the rat. If there was still pain
reflex, supplemental doses of 0.10 ml of ketamine were administered as needed
to ensure that the rat was heavily sedated. When rats were sedated, they were
transcardially perfused with physiological saline (0.9% sodium chloride; pH 7.4)
followed by 4% paraformaldehyde in 0.1 M sodium phosphate buffer (PB; pH
7.4). Following the perfusion, brains were extracted from the skulls of the rats
and stored in small glass containers with the fixative solution (4%
paraformaldehyde in 0.1 M PB). 12-16 hours later, the brains were transferred
into PB (2 X 12 h). After being in the PB, the brains were then stored in 30%
surcrose in PB until they had sunk to the bottom of the glass containers. With
the use of a rat brain matrix (RBM-4000C, ASI Instruments, Warren, Ml, USA),
each brain was sectioned into the forebrain and hindbrain at the caudal portion of
the mammillary bodies, and stored at -80°C until further processing. The
hindbrain, which included the midbrain raphe complex and locus coeruleus
complex, was sliced into 30pm sections using a cryostat (Leica CM1900, Leica
Microsystems Ltd., Buckinghamshire, UK). The sections were placed in 6
different wells containing a cryoprotectant solution (30% ethylene glycol, 20%
glycerol in 0.05 M PB; pH 7.4) in a 24 well-culture plate. Each well contained a
representative set of sections at 180pm intervals throughout the midbrain raphe
complex. After the slicing was completed in the cryostat, the sections were
stored at -20°C.

34

Immunohistochemistrv: Tryptophan Hvdroxvlase (TPH) and c-Fos
A set of hindbrain sections, including the midbrain complex, was removed
from one of the 6 wells in a 24-well tissue culture plate. The tissue sections from
each animal were placed in a 12-well tissue culture plate where the tissue was
free-floating in 1 ml solutions at room temperature, and gently shaken on an
orbital shaker throughout the immunohistochemistry. All tissue underwent a
double-immunostaining process using primary antibodies for the protein product
of the immediate early gene, c-fos (rabbit anti-c-Fos polyclonal antibody, Cat. No.
PC38, Lot No.D00109969,1:3000; Calbiochem, EMD Chemicals, Gibbstown, NJ,
USA) and TPH (sheep anti-TPH antibody, Cat. No. T8575, Lot No. 010M1152,
1:12,000; Sigma-Aldrich, St. Louis, MO, USA). Immunohistochemistry was run
simultaneously for all rats in experiment 1 in order to limit variability in the
staining process. All washes or rinses during the staining process were 15min
each, unless otherwise noted. On the first day of the immunostaining, tissue was
rinsed from the cryoprotectant twice in 0.05 M phosphate buffered saline (PBS),
then placed in 1% hydrogen peroxide in 0.05 M PBS, and followed by two rinses
in 0.05 M PBS. Then the tissue was washed in 0.05 M PBS containing Triton X100 (PBST; 0.03%), and incubated overnight with rabbit anti-c-Fos antibody in
0.01% PBST with 0.01% sodium azide. 12-16 hours later, on day 2, the antibody
was rinsed off twice in 0.05 M PBS, followed by a 90 min incubation in a
biotinylated donkey anti-rabbit secondary antibody (Cat. No. 711065152, Lot
No. 104183,1:500; Jackson ImmunoResearch, West Grove, PA, USA) in 0.05 M
PBS. Then the tissue was rinsed twice in 0.05 M PBS, followed by a 90 min
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incubation with an avidin-biotin-peroxidase complex (Elite ABC reagent, Cat. No.
P K -6106,1:200; Vector Laboratories, Burlingame, CA, USA). Tissue was then
rinsed twice with 0.05 M PBS, followed by incubation in a peroxidase chromogen
substrate (Vector SG; Cat. No. SK-4700; Vector Laboratories; diluted as
recommend by vendor) in 0.05 M PBS for 32 min. Immediately after the
chromogen reaction was complete, the tissue was rinsed in 0.05 M PBS two
separate times to terminate the reaction. Tissue was washed in 1% hydrogen
peroxide in 0.05 M PBS, followed by two rinses in 0.05 M PBS, and then
incubated with sheep anti-TPH antibody in 0.1% PBST with 0.01% sodium azide
overnight. 12-16 hours later, on day 3, the antibody was rinsed off with two
washes in 0.05 M PBS, followed by a 90 min incubation in a biotinylated rabbit
anti-sheep secondary antibody (Cat. No. P K -6106,1:200; Vector Laboratories,
Burlingame, CA, USA) in 0.05 M PBS. Then the tissue was washed twice in 0.05
M PBS followed by a 90 min incubation with an avidin-biotin-peroxidase complex
(Elite ABC reagent, Cat. No. P K -6106,1:200; Vector Laboratories, Burlingame,
CA, USA). The tissue was rinsed twice with 0.05 M PBS, then placed in a
peroxidase chromogen substrate solution consisting of 0.01% 3,3'diaminobenzidine tetrahydrochloride (DAB) in 0.05 M PBS, with the reaction
activated prior to use with 0.005% hydrogen peroxide, for 80 min. The result of
the reaction was faint, so the tissue was rinsed twice in 0.05 M PBS, and
incubated once more with sheep anti-TPH antibody in 0.1% PBST with 0.01%
sodium azide overnight, increasing the concentration of TPH from 1:12,000 to
1:8,000. 12-16 hours later, on day 4, all steps were the same as day 3
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(excluding primary antibody). Following a successful reaction in DAB, the tissue
was washed twice in 0.05 M PBS to stop the reaction, and then placed 0.1 M PB
with 0.01% sodium azide at 4°C. Immunostaining of c-Fos was a blue/black
color localized to the nucleus, while immunostaining of TPH was an
orange/brown color localized to the cytoplasm. Following immunostaining, the
tissue was rinsed briefly in 0.15% gelatin in distilled water, then mounted on
microscope slides (VistaVision, Cat No. 16004-390, VWR, West Chester, PA,
USA). The mounted tissue was dehydrated through the use of a series of graded
alcohols (70%, 95%, and 100% ethanol) and cleared with xylene. Cover slips
were then secured on the slides using Entellan mounting medium (Electron
Microscopy Science, Hatfield, PA, USA).
Immunohistochemistry; Tvrosine Hvdroxvlase (TH) and c-Fos
This process was virtually identical to the TPH protocol that was
previously described with exceptions in two key areas. On day 2, the primary
antibody that was used was TH (rabbit anti-TH, Cat. No. AB152, Lot No.
21030329,1:8000; Chemicon, Billerica, MA, USA) and was incubated for 12-16
hours. On day 3, the secondary antibody that was used was a biotinylated
donkey anti-rabbit secondary antibody (Cat. No. 711065152, Lot.No. 104183,
1:500; Jackson ImmunoResearch, West Grove, PA, USA) in 0.05 M PBS for a 90
min incubation.
Results
Open Field
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A One-way analysis of variance (ANOVA) revealed no significant differences
between ISS and control rats for any of the behavioral measures (i.e, rearing,
grooming, comer facing, time spent in the outer/inner sections and locomotor
activity) in the open field test (p’s > 0.05; Figures 1-6). The open field data was
analyzed in the same format as Hale et al. (2008a) in terms of the grouping the
data in five minute segments (i.e., 0-5 min and 5-10 min).
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Figure 1. Mean (+/- SEM) frequencies of behavior in the open field (0-5 min).
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Figure 2. Mean (+/- SEM) time in sec spent in the outer or inner section of the
open field (0-5 min).
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Figure 3. Mean (+/- SEM) number of line crossings in the outer or inner section of
the open field (0-5 min).
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Figure 4. Mean (+/- SEM) frequencies of behavior in the open field (5-10 min).
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Figure 5. Mean (+/- SEM) time in sec spent in the outer or inner section of the
open field (5-10 min).
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Figure 6. Mean (+/- SEM) number of line crossings in the outer or inner section of
the open field (5-10 min).
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Immunohistochemsitrv for the DRN
Cell counting occurred in the dorsal part of the dorsal raphe nucleus (DRD) at 8.18mm Bregma (Paxinos & Watson 1997). The immunohistochemistry data for
three rats was omitted due to the quality of the tissue. A Pearson’s r revealed
that the inter-rater reliability correlations were high for all three cell counts:
r(43)=0.93 for c-Fos, r(43)=0.90 for TPH-stained neurons, and r(43)=0.95 for
double-labeled neurons (p<0.001 for all counts). A repeated measures ANOVA
was used with mean cell counts for c-Fos, TPH-stained (serotonergic) neurons,
and double-labeled (presentation of c-Fos and TPH in same cell) as the withinsubject factors and treatment as the between-subject factor. There was a
significant difference for cell counts [F(2,78) = 307.68, p < 0.001], but there was
not a significant effect for cell counts X treatment interaction [F(10,78) = 0.570, p
= 0.833]. There was also no significant difference between the treatment groups
[F(5,39) = 0.527, p = 0.755]. This indicated that the number of counts between cFos, TPH-stained neurons, and double-labeled neurons did differ. However, the
cell counts did not differ among treatment groups (Figures 7 & 8).
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Figure 7. Mean (+/- SEM) counts for cells containing c-Fos, TPH, and both c-Fos
and TPH (double-labeled) in the DRD (dorsal part of the dorsal raphe nucleus) at
-8.18mm Bregma.

Figure 8. Photomicrograph representing a sample of c-Fos expression in
serotonergic and non-serotonergic neurons in the mid-rostrocaudal dorsal raphe
nucleus (-8.18mm Bregma). Black boxes indicate regions with higher levels of
magnification in inserts in the lower left part of the panel. Black arrows illustrate
examples of c-Fos (represented by a blue/black coloring of the nucleus), white
arrowheads indicate TPH-stained cells (represented by brown/orange coloring of
the cell body), and black arrowheads indicate the presentation of both c-Fos and
TPH in the cell (double-labeled neurons).
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Immunohistochemsitrv for the LC
Cell counting occurred between -9 .8 and -1 0 .0 4 mm Bregma (Paxinos &
Watson 1997). The immunohistochemistry data for six rats was omitted due to
missing sections. A Pearson’s r revealed that the inter-rater reliability
correlations were high for all three cell counts: r(40)=0.97 for c-Fos, r(40)=0.92
for TH-stained neurons, and r(40)=0.97 for double-labeled neurons (p<0.001 for
all counts). A repeated measures ANOVA was used with mean cell counts for cFos, TH-stained (noradrenergic) neurons, and double-labeled (presentation of cFos and TH in same cell) as the within-subject factors and treatment as the
between-subject factor. There was a significant difference for cell counts
[F(2,72) = 940.94, p < 0.001], but there was not a significant effect for cell counts
X treatment interaction [F(10,72) = 0.879, p = 0.557]. There was also no
significant difference between the treatment groups [F(5,36) = 0.982, p = 0.442].
This indicated that the number of counts between c-Fos, TH-stained neurons,
and double-labeled neurons did differ. However, the cell counts did not differ
among treatment groups (Figures 9 & 10).
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Figure 9. Mean (+/- SEM) counts for cells containing c-Fos, TH, and both c-Fos
and TH (double-labeled) in the LC between -9 .8 and -1 0 .0 4 mm Bregma.

Figure 10. Photomicrograph representing a sample of c-Fos expression in
noradrenergic and non-noradrenergic neurons. Black boxes indicate regions
with higher levels of magnification in inserts in the lower left part of the panel.
Black arrowheads indicate the presentation of both c-Fos and TH in the cell
(double-labeled neurons).
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Discussion
The non-significant results for the open field test could mean that
exposure to the ISS model may better represent pathological anxiety. Indeed, if
this is the case, Prut and Belzung (2003) have suggested that the open field test
may not be a valid model to characterize pathological anxiety. In terms of the
immunohistochemistry, the cell counting that occurred in the DRD at -8.18mm
Bregma was chosen because it is densely populated with serotonergic neurons
and has a strong association with anxiety. Expanding on the DRD’s association
with anxiety: it is innervated by structures in the forebrain (e.g., BNST), which
control anxiety levels; plays a role in mediating emotional behavior; and is a key
area that responds specifically to stress- or anxiety-provoking stimuli (Lowry et
al., 2008). The selected sections between -9 .8 and -1 0 .0 4 mm Bregma were
chosen because the largest portion of noradrenergic neurons are found in this
rostrocaudal area (Dawe, Huff, Vandergriff, Sharp, O’Neill, & Rasmussen, 2001)
and this area is innervated by amygdala, which is associated with fear and
anxiety (Bishop, 2007).
The results obtained from the current experiment for both the c-Fos/TPH
and c-Fos/TH protocols revealed no differences between the treatment groups.
With the similar results between the stress and control conditions, this could
mean that serotonergic neurons may not play as large of a role with regard to
ISS — a consistent finding with our model (Christianson et al., 2008b; Drugan et
al., 2010). However, NSRIs have been effective in alleviating ISS-induced
deficits (Drugan et al., 2010), even though there was no difference at the cellular
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level for noradrenergic neurons in the current experiment. The lack of cellular
results could be due to when the assessment of c-Fos occurred (approximately
24h after ISS exposure), since c-Fos is a short-lived protein with a half-life of
approximately two hours. This alludes to the importance of the time course
associated with c-Fos, and could provide an opening for other longer lasting Fos
measures (e.g., FosB or AFosB) as neural markers (Kov£cs, 1998).
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CHAPTER III

EXPERIMENT TWO

Method
Contrary to experiment 1, SE was used as the dependent measure rather
than the open field test (described below). The rationalization to use SE as a
different behavioral endpoint to measure anxiety was derived from prior work by
Christianson, Drugan, Flyer, Watkins, and Maier (2013) who found a significant
difference in SE for rats exposed to a cold water continuous swim (19°C) with a 5
min swim duration. Differences in SE were noted at 1hr and 24hr post-stress.
However, for our model, looking at the effects 1hr post-ISS may yield
confounding results, as rats demonstrate hypothermic tendencies for at least 2hr
post-ISS (Levay, Govic, Hazi, Flannery, Christianson, Drugan et al., 2006). With
that known, experiment 2 was a pilot study to determine the optimal time point
post-ISS (15°C; 100-5 sec swims) to evaluate SE.
Subjects
All rats were exposed to ISS. 16 male Sprague-Dawley rats (SAS
Derived, Charles River Labs, NY, USA) were divided into two groups: No Context
Re-Exposure and Context Re-Exposure with 8 rats/group. All procedures were
reviewed and approved by the University of New Hampshire IACUC (APPENDIX

B).
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Apparatus
Juvenile Social Explpration. This censisted of a single, plastic tub cage
(20.3cm height, 47.6cm length, and 25.4cm width) that contained wood shavings
as bedding and a metal wire lid, but free of food and water. Test sessions were
recorded with RT counter/timer version 2.1 (an open-source laboratory timer
written by John Christianson, 2007) used by Christianson et al. (2008a).
Procedure
On days 1 (48hr pre-ISS; SE 1) and 2 (24hr pre-ISS; SE 2) of
experimentation, rats underwent baseline tests for SE. Two baseline tests were
administered to ensure that the amount of time the rats spent exploring the
juveniles was consistent across multiple time points. For the test itself, adult (4
rats/cage) and juvenile (6 rats/cage) rats were group housed and were taken
from the vivarium and placed in a separate room from either the vivarium or ISS
room. All rats were given 60 min to become acclimated to the novel
environment, then a juvenile rat (28-32 days old) was placed in a separate cage
with an adult rat for three minutes where exploratory behaviors (e.g., sniffing,
pinning, or grooming the juvenile) of the adult rat was recorded. After three
minutes the juvenile was removed, and the adult rat was returned to its home
cage (Christianson et al., 2008a).
Day 3 was the same as the first day of experimentation for experiment one
with the exception of there being no CC condition, only ISS. Following ISS
exposure, adult rats were individually housed (this was the housing condition for
the remainder of the experiment). Juvenile rats always remained group housed
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throughout the experiment. The adult rats were divided into two groups: No
Context Re-Exposure and Context Re-Exposure. The first group would
experience ISS, but was not re-exposed to the ISS apparatus at later time points.
For the Re-Exposure group, those rats were re-exposed to the ISS apparatus for
10 minutes prior to each SE time point post-ISS. Regardless of the group, SE
testing occurred at 3h (SE 3), 5h (SE 4), 8h (SE 5), and 24h (Day 4; SE 6) postISS. All of these SE tests were compared to the baseline measures— SE 1 and
SE 2. The exact procedure described for SE on days 1 and 2 remained the
same with the exception that the Re-Exposure group only experienced a 50 min
acclimation to the SE room prior to testing. Important to note, is that all of the
time points selected occurred during the light cycle.
Results
A Pearson’s r revealed that the inter-rater reliability was high for all SE
tests: r(14)=0.99 for SE 1-SE 6 (p<0.001). A one way ANOVA was conducted to
determine the statistical significance between groups, and revealed a significant
main effect [F(11,95) = 2.713, p = 0.005]. Post hoc Fisher’s Least Significant
Difference (LSD) tests indicated that the No Re-Exposure/SE 1 and SE 2,
respectively, differed from SE 4 (p = 0.005; p = 0.006), SE 5 (p = 0.015; p =
0.017), and SE 6 (p = 0.002; p = 0.003). The same post hoc tests also revealed
that the Re-Exposure/SE 1 and SE 2, respectively, only differed from SE 5 (p =
0.016; p = 0.014; Figure 11).
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Figure 11. Mean (+/- SEM) time in sec of social exploration. All rats were
exposed to ISS, but were divided into No Re-Exposure or Re-Exposure groups.
There were 6 social exploration time points (48h pre-ISS = SE 1; 24h pre-ISS =
SE 2; 3h post-ISS = SE 3; 5h post-ISS = SE 4; 8h post-ISS = SE 5; 24h post-ISS
= SE 6). ‘ Significant difference (p<0.05) from SE 1 and SE 2 for only the No
Context Re-Exposure condition. “ Significant difference (p<0.05) from SE 1 and
SE 2 for both experimental conditions.

Discussion
Even though there was no discernible difference noted for the open field test in
experiment 1, the results for the current experiment provide the first behavioral
change of anxiety behavior in response to ISS exposure. Others have noted a
reduction in SE 24h post-stress without re-exposure to the stressful environment
(Christianson, Jennings, Ragole, Flyer, Benison, Barth, etal., 2011), and most
studies have looked at the effects of juvenile SE 12 hours or later following stress
exposure (Christianson et al., 2008a, 2011). However, because SE has never
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been explored with regard to ISS, it was vital to assess multiple time points to
ensure an effect was possible. The inconsistent results of the context re
exposure group was likely due to the fact that the 60 min acclimation period in
the SE testing room was disrupted when the animals were placed back in the ISS
chamber. So, in the subsequent experiment, no context re-exposure will occur.
Since there was no statistical difference between SE 1 and SE 2, only one SE
time point pre-stress will be used for future experiments.
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CHAPTER IV

EXPERIMENT THREE

Method
With the results being much more consistent and reliable for the no
context re-exposure group, I did not plan to pursue the context re-exposure
condition for experiment 3. Moreover, the goal of the previous experiment was to
select an optimal time point. A 24h SE time point seemed ideal for experiment 3
for a few reasons:1 This time point was consistent with our past work in our
laboratory that has looked at the effects of ISS 24h later on various behavioral
endpoints (Christianson & Drugan, 2005; Drugan, Eren, Hazi, Silva, Christianson,
& Kent, 2005; Drugan et al., 2010; Warner & Drugan, 2 0 1 2 )2 This was the same
time point that was investigated in experiment 1 3 Due to our general interest in
serotonin and norepinephrine with our ISS model, there have been previous
reports looking at the mechanistic functions of dorsal raphe nucleus and locus
coeruleus at a 24h time point. At 24h post-uncontrollable stress, there was an
increase in the firing rate of serotonin in the dorsal raphe nucleus (Rozeske et al.,
2011) and a decrease in the firing rate of norepinephrine in the locus coeruleus
(Pavcovich & Ramirez, 1991). 4 In the small chance that the multiple SE tests
affected performance 24h post-ISS, a 24 time point was measured again to
provide a pure assessment of the results. This was helpful to ensure that fatigue
or hypothermia was not a potential confound for the reduced SE times. The
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methodology was identical to experiment 2 with the exception of the groups and
only two SE time points were used.
Subjects
16 male Sprague-Dawley rats (SAS Derived, Charles River Labs, NY,
USA) were divided into two groups: ISS and home cage control (HCC) with 8
rats/group. A CC group, as seen in experiment 1, was not included for this
experiment. The reason being is that past results between the CC and HCC
groups have been comparable (Christianson & Drugan, 2005), and most
research involving an uncontrollable stressor only uses a HCC group
(Christianson et al., 2008a, 2009, 2010). All procedures were reviewed and
approved by the University of New Hampshire IACUC (APPENDIX C).
Procedure
Day 1, all adult and juvenile rats were group housed (4 rats/cage) and
experienced SE 1 (24h pre-ISS). Day 2, only adult rats were individually housed
and this was the housing condition for the remainder of the experiment. On this
same day, for the ISS condition only, rats were exposed to the ISS apparatus.
HCC rats remained in the vivarium during ISS sessions. Day 3, all rats
experienced SE 2 (24 post-ISS).
Results
A Pearson’s r revealed that the inter-rater reliability was high for all SE
tests: r(14)=0.99 for SE 1 and SE 2 (p<0.001). A one way ANOVA was
conducted to determine the statistical significance between groups and revealed
a significant main effect [F(3,29) = 4.757, p = 0.009]. Post hoc LSD tests
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indicated that ISS/SE 2 significantly differed from ISS/SE 1 (p = 0.001), HCC/SE
1 (p = 0.011), and HCC/SE 2 (p = 0.018; Figure 12). One rat was removed from
the analysis because he failed to exceed 20 seconds of social exploration during
the baseline testing.

80-|

Post-ISS

Pre-ISS
60-

c
o

IS
£ 40-

ft

UJ

3
o

8 20

-

24h

24h

Time

Figure 12. Mean (+/- SEM) time in sec of social exploration. There were 2 social
exploration time points (24h pre-ISS = SE 1; 24h post-ISS = SE 2). * ISS group
at SE 2 significantly differed (p<0.05) from all other conditions and SE time
points.

Discussion
The present experiment replicates the reduction of SE following ISS
exposure. Importantly, these results support the trans-situational value of the
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ISS model. ISS-induced deficits have been noted for tasks assessing behavioral
depression (Drugan et al., 2010), learning and memory (Warner & Drugan, 2012)
and now anxiety. As stated earlier, this SE reduction 24h post-stress has been
seen in other models (Christianson et al., 2008a, 2011).
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CHAPTER V

GENERAL DISCUSSION
We have learned much since the ISS model was first described by Brown,
Hurley, Repucci, and Drugan (2001). Researchers illustrated the feasibility of
using a triadic design (i.e. escapable stress, yoked-inescapable stress and a
non-stressed control) with the ISS model, which was previously only associated
with the tailshock paradigm (Maier et al., 1986). Controllability over the stressor
(i.e., escapable swim stress) was not a factor at 23°C (Brown et al., 2001), but
was a factor at 30°C (Drugan et al., 2005) for ISS in regards to behavioral
depression (or immobility) in the FST. At 30°C, rats exposed to inescapable
swim stress experienced greater immobility compared to rats that experienced
escapable swim stress (Drugan et al., 2005). The stressor appeared to have a
more severe impact at 23°C since both inescapable and escapable stress groups
showed a significant reduction for immobility in comparison to controls (Brown et
al., 2001), and this ISS-induced deficit has since been replicated for inescapable
stress using 15°C (Christianson & Drugan, 2005; Drugan et al., 2010). The
impairments associated with ISS extend beyond immobility, as there have been
instrumental (Christianson & Drugan, 2005) and spatial (Warner & Drugan, 2012)
learning deficiencies as well. Furthermore, stress-induced analgesia noted for
inescapable tailshock (Drugan et al., 1985; Maier, Davies, Grau, Jackson,
Morrison, Moye, et al., 1980) was also observed for inescapable swim stress
(Brown et al., 2001).
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There have also been distinct differences between inescapable shock and
swim paradigms. In response to alcohol, inescapable shock potentiated ataxic
effects (Drugan, Coyle, Healy, & Chen, 1996) while inescapable swim either
attenuated or had no influence on ataxia (Brown et al., 2001; Drugan, Wiedholz,
Holt, Kent, & Christianson, 2007; Tayyabkhan, Mammola, & Drugan, 2002). In
addition, there appear to be varying neurochemical systems regulating these
different forms of inescapable stress. Learned helplessness resulting from
inescapable shock is believed to derive from a serotonergic activation (Amat et
al., 1998) and noradrenergic inactivation, (Amat et al., 2004), as inescapable
shock produced large increases in 5-HT (Amat et al., 1998) and decreases in
norepinephrine (Weiss & Simson, 1986). Fluoxetine, an SSRI, has been shown
to alleviate the behavioral deficits imposed by inescapable shock (Valentine,
Dow, Banasr, Pittman, & Duman, 2008). However, fluoxetine has had no impact
on the behavioral deficits associated with ISS (Christianson et al., 2008; Drugan
et al., 2010), while NSRIs (e.g., desipramine and reboxetine) have mitigated such
behavioral deficits (Drugan et al., 2010; Warner & Drugan, 2012). As a result,
the nature of the stressor can have a profound influence on both the behavioral
and neurological outcomes.
A key characteristic of uncontrollable stress is that it is believed to be
trans-situational, meaning once the subject is removed from the original stressful
encounter, the resulting experience is capable of altering the subject’s behaviors
in different environments (Maier & Watkins, 2005). Results of the first
experiment were inconsistent with this pattern as assessed via the open field
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test. This open field result also differed from shock studies, which have revealed
shock-induced behavioral deficits in the open field at 24h (Weyers, Bower, &
Vogel, 2008) and 48h (Li, Yang, Yue, Liu, Yu, Wang et al., in press) post-shock
stress. The difference in the behavioral outcomes of the open field between
inescapable shock and swim was intriguing. Perhaps, inescapable shock is a
more taxing stressor in comparison to inescapable swim, but both, as previously
described, have resulted in various deficits, and there is also a noted elevation in
corticosterone for animals exposed to both inescapable shock (Maier, Ryan,
Barksdale, & Kalin, 1986) and swim (Drugan et al., 2005). Because the open
field results are one of the few instances where inescapable shock and swim
vary, the ISS apparatus may provide a belter representation of pathological
anxiety of which the open field may not validly measure (Prut & Belzung, 2003).
Later experiments provided justification of the trans-situational experience
of ISS, and the first demonstration on anxiety behavior, as rats exposed to ISS
had significant reductions in SE for both experiment 2 and 3. Although the transsituational effects of ISS exposure have been suggested in the past using the
FST (Brown et al., 2001; Christianson & Drugan, 2005; Drugan et al., 2005;
2010) and MWM (Warner & Drugan, 2012), the contextual similarity of water
between all of the paradigms employed (i.e., FST, and MWM) could act as a cue
for remembering the ISS paradigm. An ISS-induced deficit for the SE tests
provides further validation for the trans-situational value of this particular
uncontrollable stressor. The importance of this evidence is emphasized, as
water did not serve as a contextual cue in this case, and this was also the first
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behavioral measure of anxiety to reveal a significant impairment following ISS
exposure. The SE reduction 24h post-stress is also comparable to the results
seen for inescapable shock (Christianson et al., 2008a, 2011). Additionally, for
both experiment 2 and 3, the ISS-induced deficit associated with SE occurred
24h after the stressor, which is consistent with other behavioral endpoints in our
laboratory (Drugan et al., 2010; Warner & Drugan, 2012).
While we have investigated a variety of behavioral endpoints following
exposure to ISS, we have yet to examine the cellular mechanisms associated
with the resulting ISS paradigm. Experiment 1 was intended to shed light on this
new area. However, no significant difference between any of the groups was
identified when comparing the stress-induced activation of serotonergic neurons.
This result was consistent with expectations based on previous pharmacological
manipulations in our laboratory (Christianson et al., 2008; Drugan et al., 2010),
and indicated that norepinephrine may cause the impairments associated with
the ISS model (Drugan et al., 2010; Warner & Drugan, 2012). Results of
experiment 1 also demonstrated that there was no significant difference in
noradrenergic activity for rats. Importantly, baseline assessment (i.e., not being
exposed to the open field) of ISS exposure in this experiment revealed no
difference in neurological activation (with regard to serotonergic and
noradrenergic activity) between the controls. A contributing factor to the lack of
differences between groups may be due to the short-lived expression of c-Fos.
In general, c-Fos is expressed in most cell types at all times in either low or
undetectable levels and can become more readily transparent through exposure
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to various stimuli (Eferl & Wagner, 2003). Following acute stress, the maximum
amount of c-Fos protein is expressed at 1-3 hours, and gradually disappears
from detection at 4-6 hours. (Cullinan, Herman, Battaglia, Akil, & Watson, 1995;
Kovacs, 1998; Kovacs & Sawchenko, 1996). However, past studies have noted
significant elevations in c-Fos exposure for both serotonergic and nonserotonergic cells in the dorsal raphe nucleus merely from exposure to the open
field arena (Hale et al., 2008a). So, it was surprising that exposure to the open
field arena 90 min prior to sacrificing the animals for experiment 1 did not yield
some type of variation from the home cage condition.
Given this information, differences may still exist at the cellular levels for
serotonergic and noradrenergic neurons resulting from ISS exposure, but
different methods need to be employed upon further exploration such as
assessing IHC with SE, assessing IHC shortly after ISS, or using a different Fos
protein. The following expands on these three points.1 Investigation of the
cellular mechanisms associated with SE exposure noted in experiment 3.
Exposure to the open field for experiment one may not have provided a strong
enough stimulus to elicit a disparity between experimental conditions.

In both

experiment 2 and 3, there was a noted SE reduction for rats exposed to ISS. As
a result, the SE task appears to provide varying levels of anxiety for rats exposed
to ISS or a control condition. It will be important to consider the neurological
implications previously described with this particular anxiety-related measure, as
the evaluation of c-Fos following juvenile social exploration has not been
discussed in the literature. In taking this into consideration, data analysis will be
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explored in the near future for the involvement of cellular mechanisms in
experiment 3 . 2 The assessment of c-Fos must occur shortly after the rats have
experienced the ISS condition to assess a baseline measure of the paradigm.
Two hours following ISS exposure may be an ideal time to evaluate c-Fos in the
paradigm, as the rats are no longer in a hypothermic state (Levay et al., 2006)
and the maximum amount of c-Fos expression occurs 1-3 hours following a
stressor (Cullinan, Herman, Battaglia, Akil, & Watson, 1995; Kovacs, 1998;
Kovacs & Sawchenko, 1996). Two hours post-inescapable stress has also been
used for tailshock to assess the protein product of c-Fos (Christianson et al.,
2 0 1 1 ).3 Implementing different neural markers (e.g., FosB and Fos-related
antigens) to evaluate cellular mechanisms. FosB has a half-life of 9.5 hours
following acute challenges, which would likely ensure protein expression upon
further behavioral testing (e.g., social exploration) on the same day of the ISS
procedure. A variant of FosB is AFosB. AFosB is able to maintain protein
expression on a longer basis. Depending on the particular protein of AFosB, it
can have a half-life at 28 h (Fos-related antigen-1) or 208 h (Fos-related antigen2) in response to repeated stimuli (Kovacs, 1998). Utilizing FosB or AFosB as a
neural marker may appear to be a favorable option in assessing stress- or
anxiety-related models that have larger gaps of time between testing in our
laboratory for subsequent studies.
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Conclusion
Overall, the experiments discussed provided further insight to the ISS
paradigm. These experiments revealed the first behavioral ISS-induced deficit
associated with an anxiety behavior (i.e., SE reduction), which supports the
trans-situational value of our stressor. The experiments also validated the ISS
model as an animal model of depression appropriate for examining the common
comorbidity of anxiety and depression for people suffering from major depression
(Wheeler, Blankstein, Antony, McCabe, & Bieling, 2011); and also suggests that
the ISS paradigm is a model for post-traumatic stress disorder. As our laboratory
has not previously investigated cellular mechanisms, the first experiment
provided an enlightening initial step for subsequent experiments. It is now known
that distinguishable c-Fos expression is not as readily present approximately 24h
following exposure to ISS. As a result, future immunohistochemistry experiments
must carefully assess the time course of various Fos proteins.
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APPENDIX A

University of New Hampshire
Research Integrity Services, Service Building
51 College Road, Durham, NH 03824-3585
Fax: 603-862-3564
04-Apr-2012
Drugan, Robert C
Psychology, Conant Hall
Durham, NH 03824

IAC U C # : 120302
P ro je c t: Intermittent Swim Stress Effects on Anxiety Behavior
C a te g o ry : E
A p p ro v a l D a te : 28-Mar-2012
The Institutional Animal Care and Use Committee (IACUC) reviewed and approved the protocol
submitted for this study under Category E on Page 5 of the Application for Review of Vertebrate
Animal Use in Research or Instruction - Animal use activities that involve accompanying pain or
distress to the animals for which appropriate anesthetic, analgesic, tranquiltrlng drugs or other
methods for relieving pain or distress are not used.
Approval is granted for a period of three years from the approval date above. Continued
approval throughout the three year period is contingent upon completion of annual reports on
the use of animals. At the end of the three year approval period you may submit a new
application and request for extension to continue this project Requests for extension must be
filed prior to the expiration of the original approval.

P le ase N o te :
1. All cage, pen, or other animal identification records must include your IACUC # listed above.
2. Use of animals in research and instruction is approved contingent upon participation in the
UNH Occupational Health Program tor persons handling animals. Participation is mandatory
tor all principal Investigators and their affiliated personnel, employees of the University and
students alike. A Medical History Questionnaire accompanies this approval; please copy and
distribute to all listed project staff who have not compiled this form already. Completed
questionnaires should be sent to Dr. Gladi Porsche, UNH Health Services.
If you have any questions, please contact me at 862-4629 or Julie Simpson at 862-2003.
IACUC,

i/e o n c tu e r,

Vice Chair
cc:

File
Warner, Timothy
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Appendix B

University of New Hampshire
Research Integrity Services, Service Building
51 College Road, Durham, NH 03824-3585
Fax: 603-862-3564
02-Jan-2013
Drugan, Robert C
Psychology, Conant Hall
Durham, NH 03824

IAC U C # : 121102
P ro je c t: Optimal Anxiogenic Time Point Following Intermittent Swim Stress Determined by
Social Exploration
C a te g o ry : E

A p p ro v a l D a te : 13-Dec-2012
The Institutional Animal Care and Use Committee (IACUC) reviewed and approved the protocol
submitted for this study under Category E on Page 5 of the Application for Review of Vertebrate
Animal Use in Research or Instruction - Animatuse activities that Involve accompanyingpain or
distress to the animals for which appropriate anesthetic, analgesic, tranquiiding drugs or other
methods for relieving pain or distress are not used.
Approval is granted for a period of three years from the approval date above. Continued
approval throughout the three year period is contingent upon completion of annual reports on
the use of animals. At the end of the three year approval period you may submit a new
application and request for extension to continue this project. Requests for extension must be
filed prior to the expiration of the original approval.

P lease N o te :
1. All cage, pen, or other animal identification records must include your IACUC # listed above.
2. Use of animals in research and instruction is approved contingent upon participation in the
UNH Occupational Health Program for persons handling animals. Participation is mandatory
for all principal investigators and their affiliated personnel, employees of the University and
students alike. Information about the program, including forms, Is available at
http://unh.edu/research/occuoational-health-Droaram-animal-handlers.
If you have any questions, please contact either Dean Elder at 862-4629 or Julie Simpson at
862-2003.
For the IACUC,

Jill A. McGaughy, Ph.D.
Chair
oc:

File
Warner, Timothy
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Appendix C

University of New Hampshire
Research Integrity Services, Service Building
51 College Road, Durham, NH 03824-3585
Fax: 603-862-3564
14-Mar-2013
Drugan, Robert C
Psychology, Gonant Hall

Durham, NH 03824

IAC U C # : 130201
Project: Anxiogenic Effects of Intermittent Swim Stress at a 24h Time Point Determined by
Social Exploration
C a te g o ry : E
A p p ro v a l D a te : 21-Feb-2013
The Institutional Animal Care and Use Committee (IACUC) reviewed and approved the protocol
submitted for this study under Category E on Page 5 of the Application for Review of Vertebrate
Animal Use in Research or Instruction - Animal use activities that involve accompanying pain or
distress to the animals for which appropriate anesthetic, analgesic, tranquiiizing drugs or other
methods for relieving pain or distress are not used.
Approval is granted for a period of three years from the approval date above. Continued
approval throughout the three year period is contingent upon completion of annual reports on
the use of animals. At the end of the three year approval period you may submit a new
application and request for extension to continue this project. Requests for extension must be
filed prior to the expiration of the original approval.

P le ase N o te :
1. All cage, pen, or other animal identification records must indude your IACUC # listed above.
2. Use of animals in research and instruction is approved contingent upon partidpation In the
UNH Occupational Health Program for persons handling animals. Partidpation Is mandatory
for all prindpal Investigators and their affiliated personnel, employees of the University and
students alike. Information about the program, including forms, is available at
http://unh.edu/research/occuoational-health-DroQram-animal-handlers.
If you have any questions, please contact either Dean Elder at 862-4629 or Julie Simpson at
862-2003.
For the

Jill A. McGaughy, Ph.D.
Chair
cc:

Rle
Warner, Timothy
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